---
figid: PMC2662041__nihms92254f1
figtitle: Cholesterol biosynthetic pathway
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC2662041
filename: nihms92254f1.jpg
figlink: /pmc/articles/PMC2662041/figure/F1/
number: F1
caption: Cholesterol biosynthetic pathway. HMG-CoA indicates 3-hydroxyl-3-methylglutaryl
  coenzyme A. HMG-CoA reductase is a rate-limiting enzyme and this blockade (statins)
  leads to the reduction of other isoprenoid intermediates as well as intracellular
  cholesterol.
papertitle: 'A novel pleiotropic effect of statins: prevention of cardiac hypertrophy
  by cholesterol-independent mechanisms.'
reftext: Hironori Nakagami, et al. Ann Med. ;35(6):398-403.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9077433
figid_alias: PMC2662041__F1
figtype: Figure
redirect_from: /figures/PMC2662041__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2662041__nihms92254f1.html
  '@type': Dataset
  description: Cholesterol biosynthetic pathway. HMG-CoA indicates 3-hydroxyl-3-methylglutaryl
    coenzyme A. HMG-CoA reductase is a rate-limiting enzyme and this blockade (statins)
    leads to the reduction of other isoprenoid intermediates as well as intracellular
    cholesterol.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Geranylgeranyl-pyrophosphate
  - Farnesyl-pyrophosphate
  - Geranyl-pyrophosphate
  - Cholesterol
  - Mevalonate
  - pyrophosphate
  - Squalene
---
